SymBio Pharmaceuticals Limited (TYO:4582)
78.00
-1.00 (-1.27%)
May 29, 2026, 3:30 PM JST
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of 5.63 billion as of May 29, 2026. Its market cap has decreased by -26.41% in one year.
Market Cap
5.63B
Enterprise Value
4.76B
Revenue
1.28B
Ranking
n/a
PE Ratio
n/a
Stock Price
78.00
Market Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 7.08B to 5.63B, a decrease of -20.50%. That is a compound annual growth rate of -1.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.63B | 12.02% |
| Dec 30, 2025 | 5.02B | -44.92% |
| Dec 30, 2024 | 9.12B | -12.48% |
| Dec 29, 2023 | 10.42B | -58.97% |
| Dec 30, 2022 | 25.40B | -42.20% |
| Dec 30, 2021 | 43.94B | 203.74% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharma Foods International | 18.67B |
| Fuso Pharmaceutical Industries,Ltd. | 17.35B |
| Taiko Pharmaceutical | 12.86B |
| Wakamoto Pharmaceutical | 9.78B |
| Morishita Jintan | 8.86B |
| Solasia Pharma K.K. | 6.55B |
| WDB coco | 6.18B |
| Nippon Chemiphar | 5.88B |